Question Bank › Management describes competitors unable to respo

Management describes competitors unable to respond to what the company is now doing

Calls Tested
500
Answered YES
3
Hit Rate
0.6%
rare by design

LeMaitre Vascular, Inc. (LMAT) — this company's answers

NO on the Q3 2021 call 2021-10-29 C+
The model's full reasoning — Q3 2021 call → NOWe need to determine if management explains why competition cannot quickly match what the company is currently winning with, grounded in present-tense facts. The three conditions: (1) current winning, real and recurring; (2) named structural reason rivals cannot follow soon; (3) runway acknowledged. Looking at the transcript, there is discussion about Artegraft, XenoSure, etc. But does management explicitly talk about competition and why they can't match? The question asks specifically about "the competition cannot quickly match what the company is currently winning with." The transcript has some discussion about Artegraft pricing and market share, but does it mention structural barriers? For example, they talk about Artegraft being a biologic graft vs synthetic, but they don't say competitors can't match. They mention that they have a price increase and didn't lose customers, but that's not about structural barriers. They also talk about XenoSure CE Mark issues resolved, but that's not about competition. The question is very specific: does management explain why competition cannot quickly match? I don't see any explicit statement about competitors being unable to match due to regulatory, capacity, etc. They talk about their own advantages but not about rivals' inability. They mention that they are growing sales force, but that's not about competition. Thus, the answer is NO.

← Back to the full LMAT analysis

Show the exact prompt the model was given
Using ONLY the supplied earnings call transcript and no outside information: On this call, does management explain — in concrete operational terms — WHY THE COMPETITION CANNOT QUICKLY MATCH what the company is currently winning with, and does it ground both the winning and the inability in present-tense facts? Answer YES when management's own words convey, in whatever form fits the business, ONE coherent competitive situation with all three present: (1) CURRENT WINNING, REAL AND RECURRING: the company is presently taking business, customers, orders, or share — actual wins in the recent period described with substance, not generic 'well positioned' claims; (2) A NAMED STRUCTURAL REASON RIVALS CANNOT FOLLOW SOON: management explains specifically what would be required for competitors to match the company's position — years of qualification, capacity that takes long to build, approvals or certifications rivals lack, accumulated data or installed relationships, integration others cannot replicate, an economic structure rivals cannot profitably copy — presented as the operative reason customers are choosing the company now, with management conveying that rivals are visibly absent, behind, failing to respond, or responding in ways that do not close the gap; and (3) RUNWAY ACKNOWLEDGED: management conveys that the protected winning continues from here — the same advantaged position applies to business still ahead — rather than describing a closing window. Answer NO if the competitive claims are generic superiority ('better product', 'great team', 'we win on value') without a specific structural barrier explained. NO if management describes intense competition, price pressure, or rivals matching it. NO if the wins are hoped for or pipeline rather than occurring. NO if the barrier is only asserted ('high barriers to entry', 'wide moat') without operational substance. NO if the window is described as temporary — a rival's brief stumble management expects to reverse. NO if the framing appears only in analyst questions management does not itself develop. Use only the supplied transcript. Answer only YES or NO.

Companies that answered YES

TickerCompanyCallDateCall grade
GRBK Green Brick Partners, Inc. Q3 2023 2023-11-01 B
UAL United Airlines Holdings, Inc. Q4 2022 2023-01-18 B
AKAM Akamai Technologies, Inc. Q4 2021 2022-02-15 B

How the model reasoned

GRBK · Q3 2023 → YESThe question is: Does management explain in concrete operational terms WHY THE COMPETITION CANNOT QUICKLY MATCH what the company is currently winning with, and ground both the winning and the inabilit...YES The transcript shows management directly attributing current wins—net new orders up 95% YoY, record gross margins, leading the industry—to concrete operational factors: superior infill locations, self-development land strategy, and the resulting lower cancellation rates and fewer competing builders due to land scarcity. These are framed as present- tense realities, with the same advantages expected to continue as the company prioritizes prime land acquisition and remains well positioned to capture long-term demand in supply-constrained submarkets.
UAL · Q4 2022 → YESThe question is: Does management explain in concrete operational terms WHY THE COMPETITION CANNOT QUICKLY MATCH what the company is currently winning with, and ground both the winning and the inabilit...YES Management describes concrete current wins in the recent period: 9% margin ahead of schedule, better relative margins, superior operational performance over holidays with fewer cancellations, better TRASM than industry peers, and highest pretax margins among network carriers in Q4.
AKAM · Q4 2021 → YESThe question is: Does management explain in concrete operational terms WHY THE COMPETITION CANNOT QUICKLY MATCH what the company is currently winning with, and ground both the winning and the inabilit...

More from the question bank

Regular buyers moved from occasional to progThe company's product is being consumed fastGeographic or market replication just starteComing out of the tunnelNew leadership already changing what the comNamed counterparty roster suddenly upgraded All questions →
Not investment advice. Artul.ai publishes AI-generated earnings-call quality grades and expected-volatility estimates — never buy or sell recommendations. We tested over 1,600 predictive hypotheses against 165,000 transcripts; the honest result, including what failed, is documented in our methodology.